NewsRadio WFLA (WFLA-AM)

American Medicine Today - Radio

NewsRadio WFLA (WFLA-AM)

  • DR. JERRY SILVER – NERVGEN PHARMA AND USING PEPTIDES TO TREAT PARALYSIS 1 6 24

DR. JERRY SILVER – NERVGEN PHARMA AND USING PEPTIDES TO TREAT PARALYSIS 1 6 24

Saturday 6th January 2024

Join Dr. Jerry Silver on 'American Medicine Today' as he shares groundbreaking advancements in using peptides to treat paralysis, now in human trials.
Explicit
10 minutes
Inspiring
Hopeful
Informative
Empowering
Transformative

About this podcast

American Medicine Today - Radio
Author:
NewsRadio WFLA (WFLA-AM)
Overview:
Categories:
Innovative Treatments & Recovery Paths
Holistic Health Innovations
Innovative Healing Arts
Sexual Stigmas & Myths
Mindful Recovery
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Peptides and Paralysis: Dr. Jerry Silver's Groundbreaking Research

Episode Overview

  • Dr. Jerry Silver discusses 40 years of research in peptide treatment for paralysis.
  • The peptide treatment shows promising results in animal trials, sparking hope for significant recovery in human trials.
  • Human trials focus on chronic spinal cord injury patients, with potential implications for stroke and Alzheimer's disease.
  • The groundbreaking research offers potential future developments in treating various conditions related to paralysis.
  • The podcast leaves you inspired by the transformative possibilities of peptide treatment for paralysis and related conditions.
The trials now run a limited group of people, 20 controls that are placebo and 20 paralyzed individuals. And so this is a so-called 2A phase trial in a limited number of people. Of course, we hope to see improvements both physiologically and hopefully, obviously, functionally in these patients.
Ever wondered if paralysis could be treated with something as small as a peptide? In this episode of 'American Medicine Today', Dr. Jerry Silver, co-inventor and scientific advisor at NerveGen Pharma, takes us on an enlightening journey through his decades-long research. Dr. Silver first caught our attention over eight years ago with his pioneering work on peptides to treat paralysis in mice. Now, he's back with thrilling updates as his research steps into the critical phase of human clinical trials.
Dr. Silver’s dedication spans 40 years, and his latest advancements offer a beacon of hope for those with chronic spinal cord injuries. But it doesn't stop there. The potential applications of this treatment extend to conditions like stroke and Alzheimer's disease, suggesting a broader impact than initially imagined. Through engaging conversation, Dr. Silver breaks down complex science into understandable nuggets, making this episode both informative and inspiring.
For anyone touched by paralysis or interested in cutting-edge medical research, this episode is a must-listen. It's a testament to how relentless pursuit and innovative thinking can pave the way for life-changing solutions.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.